JP2005206602A5 - - Google Patents

Download PDF

Info

Publication number
JP2005206602A5
JP2005206602A5 JP2005013897A JP2005013897A JP2005206602A5 JP 2005206602 A5 JP2005206602 A5 JP 2005206602A5 JP 2005013897 A JP2005013897 A JP 2005013897A JP 2005013897 A JP2005013897 A JP 2005013897A JP 2005206602 A5 JP2005206602 A5 JP 2005206602A5
Authority
JP
Japan
Prior art keywords
antibody
arginine
producing
buffer
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005013897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005206602A (ja
JP4826995B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2005206602A publication Critical patent/JP2005206602A/ja
Publication of JP2005206602A5 publication Critical patent/JP2005206602A5/ja
Application granted granted Critical
Publication of JP4826995B2 publication Critical patent/JP4826995B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2005013897A 2004-01-21 2005-01-21 抗体の変質を防止する精製方法 Expired - Lifetime JP4826995B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53750304P 2004-01-21 2004-01-21
US60/537503 2004-01-21
US63140704P 2004-11-30 2004-11-30
US60/631407 2004-11-30

Publications (3)

Publication Number Publication Date
JP2005206602A JP2005206602A (ja) 2005-08-04
JP2005206602A5 true JP2005206602A5 (enExample) 2008-03-06
JP4826995B2 JP4826995B2 (ja) 2011-11-30

Family

ID=34753090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005013897A Expired - Lifetime JP4826995B2 (ja) 2004-01-21 2005-01-21 抗体の変質を防止する精製方法

Country Status (5)

Country Link
US (3) US8084032B2 (enExample)
EP (1) EP1568710B1 (enExample)
JP (1) JP4826995B2 (enExample)
CN (1) CN1680426B (enExample)
DE (1) DE602005018406D1 (enExample)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
DE602006003108D1 (de) * 2005-03-03 2008-11-27 Ajinomoto Kk Methode zur Verbesserung der Ausbeute bei der Proteinreinigung mittels Gelfiltrationschromatographie und Arginin
US7993853B2 (en) * 2005-05-06 2011-08-09 Gen-Probe Incorporated Methods of nucleic acid target capture
CN101506222B (zh) * 2006-07-14 2013-10-02 健泰科生物技术公司 重组蛋白的重折叠
TW200821026A (en) 2006-09-08 2008-05-16 Wyeth Corp Arginine wash in protein purification using affinity chromatography
TW201516149A (zh) 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
DK2089429T3 (en) * 2006-10-19 2015-01-12 Janssen Biotech Inc PROCEDURE FOR MANUFACTURING NON-AGGREGATED ANTIBODY-FC DOMAINS
US8669045B2 (en) 2007-02-13 2014-03-11 Ajinomoto Co., Inc. Method for inactivating viruses with slightly acidic arginine
CN102089319B (zh) * 2008-05-08 2013-11-13 味之素株式会社 蛋白质的重折叠方法
JP4542172B2 (ja) * 2008-05-19 2010-09-08 日本電波工業株式会社 感知装置及び感知方法
JP5529869B2 (ja) * 2008-08-14 2014-06-25 メルク・シャープ・アンド・ドーム・コーポレーション プロテインaアフィニティークロマトグラフィーを用いる抗体の精製方法
CN104974251A (zh) 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
CA2932207A1 (en) 2008-10-20 2010-12-09 Abbvie Inc. Isolation and purification of antibodies using protein a affinity chromatography
JP2011041475A (ja) * 2009-08-19 2011-03-03 Asahi Kasei Medical Co Ltd 抗体製造方法
BR112012014937B1 (pt) * 2009-12-18 2021-01-19 Novartis Ag método de produção de um anticorpo, fragmento de anticorpo ou proteína de fusão fc purificada usando uma matriz de cromatografia de afinidade
EP2526114B1 (de) * 2010-01-22 2014-06-18 Boehringer Ingelheim International GmbH Chromatographisches verfahren zur aufreinigung von fc enthaltenden proteinen
EP2538790B1 (en) 2010-02-26 2015-07-29 Ajinomoto Co., Inc. Virus-inactivating composition containing low-molecular weight compound and arginine
EP2583973B1 (en) * 2010-06-21 2018-03-21 Kyowa Hakko Kirin Co., Ltd. Method for purifying protein using amino acid
KR101953405B1 (ko) 2011-06-01 2019-02-28 노파르티스 아게 친화성 크로마토그래피를 위한 세척 용액 및 방법
CN103608463A (zh) 2011-06-23 2014-02-26 味之素株式会社 由使具有免疫球蛋白折叠结构的蛋白和能够形成亚单元结构的蛋白融合而得到的单体蛋白组成的多聚体蛋白的制备方法
WO2014003137A1 (ja) * 2012-06-27 2014-01-03 旭化成メディカル株式会社 高アフィニティー抗体、及びその製造方法
WO2014054744A1 (ja) * 2012-10-03 2014-04-10 協和発酵キリン株式会社 培養液にアミノ酸を添加することによるポリペプチドの還元防止方法
RS57864B1 (sr) 2013-06-17 2018-12-31 De Staat Der Nederlanden Vert Door De Minister Van Vws Ministerie Van Volksgezondheid Welzijn En Spo Postupci za sprečavanje agregacije virusnih komponenti
JP6236948B2 (ja) * 2013-07-17 2017-11-29 東ソー株式会社 抗体精製用溶出液および当該溶出液を用いた抗体精製方法
CN105273041A (zh) * 2014-07-08 2016-01-27 上海中信国健药业股份有限公司 一种蛋白质亲和层析洗脱方法
AR102198A1 (es) 2014-10-09 2017-02-08 Regeneron Pharma Proceso para reducir partículas subvisibles en una formulación farmacéutica
ES2964713T3 (es) 2014-10-23 2024-04-09 Amgen Inc Reducción de la viscosidad de formulaciones farmacéuticas
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
EP3374371A4 (en) * 2015-11-09 2019-12-11 University of Notre Dame SMALL MOLECULE AFFINITY MEMBRANE PURIFICATION SYSTEMS AND USE THEREOF
HRP20160086A2 (hr) 2016-01-27 2017-08-11 Sveučilište u Zagrebu Eluens za imunoafinitetnu kromatografiju virusa i proteina
US11186858B1 (en) 2016-03-15 2021-11-30 Fresenius Kabi Deutschland Gmbh Methods for increasing biosimilarity
JP7122974B2 (ja) 2016-05-11 2022-08-22 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 変異免疫グロブリン結合ポリペプチド
EP3455241B1 (en) 2016-05-11 2022-02-23 Cytiva BioProcess R&D AB Method of cleaning and/or sanitizing a separation matrix
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
WO2017194592A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of storing a separation matrix
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
WO2018022628A1 (en) 2016-07-25 2018-02-01 Cephalon, Inc. Affinity chromatography wash buffer
AU2017312785B2 (en) 2016-08-16 2024-10-10 Regeneron Pharmaceuticals, Inc. Methods for quantitating individual antibodies from a mixture
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
KR102759512B1 (ko) 2016-10-25 2025-02-03 리제너론 파아마슈티컬스, 인크. 크로마토그래피 데이터 분석을 위한 방법 및 시스템
JP7377596B2 (ja) 2017-02-22 2023-11-10 アムジエン・インコーポレーテツド 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
JP6897761B2 (ja) * 2017-04-07 2021-07-07 コニカミノルタ株式会社 タンパク質修飾蛍光体集積粒子の精製物を製造する方法、蛍光染色液の製造方法、タンパク質修飾蛍光体集積粒子の精製物、蛍光染色液およびタンパク質修飾蛍光体集積粒子精製用フィルター
WO2019060062A1 (en) 2017-09-19 2019-03-28 Regeneron Pharmaceuticals Inc. METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREFROM
JP7158015B2 (ja) * 2017-11-09 2022-10-21 国立研究開発法人産業技術総合研究所 ポリペプチドの凝集化抑制方法
US11155575B2 (en) 2018-03-21 2021-10-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbent, devices and methods
TWI919355B (zh) 2018-07-02 2026-03-21 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
EA202192422A1 (ru) 2019-03-05 2021-12-09 Ридженерон Фармасьютикалз, Инк. Человеческий сывороточный альбумин в составах
SG11202112846RA (en) 2019-08-02 2021-12-30 UCB Biopharma SRL Methods for purifying antibodies
CN114466861A (zh) * 2019-10-04 2022-05-10 默克专利股份有限公司 蛋白a亲和色谱中单克隆抗体的洗脱
CN112898413A (zh) * 2021-04-07 2021-06-04 杭州奕安济世生物药业有限公司 采用亲和层析纯化减少抗体聚集的方法
CN113980092B (zh) * 2021-12-09 2024-05-14 上海药明生物技术有限公司 一种蛋白质亲和纯化方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1323567C (en) 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
JPH02273194A (ja) 1989-04-14 1990-11-07 Sumitomo Chem Co Ltd ヒトモノクローナル抗体の安定な精製法
EP0663925A4 (en) 1992-10-02 1997-11-19 Gen Hospital Corp AFFINITY PURIFICATION METHODS USING AMINO ACID MIMETISMS AS ELUTION REAGENTS.
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
EP1404428B1 (en) 2001-06-05 2006-07-19 Genetics Institute, LLC Methods for purifying highly anionic proteins
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
DE602006003108D1 (de) 2005-03-03 2008-11-27 Ajinomoto Kk Methode zur Verbesserung der Ausbeute bei der Proteinreinigung mittels Gelfiltrationschromatographie und Arginin
US8669045B2 (en) 2007-02-13 2014-03-11 Ajinomoto Co., Inc. Method for inactivating viruses with slightly acidic arginine
CN102089319B (zh) 2008-05-08 2013-11-13 味之素株式会社 蛋白质的重折叠方法

Similar Documents

Publication Publication Date Title
WO2006138553A3 (en) Methods of purifying fc region containing proteins
CA2482097A1 (en) Methods for isolating nucleic acids
DE602005014969D1 (de) Verfahren zur aufreinigung von albumin-konjugaten
NZ587511A (en) Purified lymphotoxin-beta-receptor immunoglobulin fusion proteins and methods of their purification
EP1568710A3 (en) Antibody purification method
WO2005047860A3 (en) Antibodies to alpha-synuclein
JP2012018171A5 (enExample)
WO2007109163A3 (en) Wash buffer and method of using
UA102503C2 (en) Interleukin-13 binding proteins
WO2006023831A3 (en) Sequential protein isolation and purification schemes by affinity chromatography
WO2003065031A1 (en) Method and apparatus for analyzing amino acid, peptide, protein, saccharide or lipid
WO2001083515A3 (en) Simulated activity of protein a displayed by ligands attached to a cellulose bead surface
WO2009139601A3 (en) Method and affinity column for purifying proteins
ATE417056T1 (de) Verfahren zur proteinreinigung
WO2007008071A3 (en) Method for detecting peptides comprising a cross-beta structure
EP1780537A4 (en) PROTEOMANALYSIS PROCESS FOR PHOSPHORYLATED PROTEIN
ATE464566T1 (de) Verfahren zur markierung phosphorylierten peptiden, komplexverbindunger, verfahren zu deren herstellung und zwischenprodukte
CA2448788A1 (en) Methods for purifying highly anionic proteins
AU2003260392A1 (en) Method for enriching a prokaryotic dna
WO2008142664A3 (en) Exposed thymidine kinase 1 peptides, ligands and methods employing the same
ATE541037T1 (de) Verfahren zur trennung und reinigung von nukleinsäure
JP2009518428A5 (enExample)
JP2009133739A5 (enExample)
ATE468343T1 (de) Verfahren zur reinigung von tacrolimus
RU2004103098A (ru) Способ прижизненного определения острой фазы стафилококкового среднего отита в эксперименте